Surgical resection for patients with the liver metastasis of gastroenteropancreatic neuroendocrine tumors: a Meta-analysis
10.3760/cma.j.issn.1673-4203.2014.09.011
- VernacularTitle:手术治疗胃肠胰腺神经内分泌瘤肝转移的Meta分析
- Author:
Yu ZHOU
;
Shuxiang SONG
;
Ping CHEN
;
Lei SHI
;
Hao WANG
;
Xinxin LIU
- Publication Type:Journal Article
- Keywords:
Neuroendocrine tumors;
Neoplasm metastasis;
Surgical procedures,operative;
Meta-analysis
- From:
International Journal of Surgery
2014;41(9):617-621
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the potential benefits of hepatic resection for patients with hepatic metastasis of gastroenteropancreatic neuroendocrine tumors.Methods A search in Cochrane Library,PubMed,Medline,Embase,CBM,Wanfang Databases for identifying randomized trails.Criteria for inclusion were established based on validity criteria by Cochrane Methods Group on screening and diagnostic tests,and correlated indexes of 10 articles including 1 567 patients were extracted for Meta-analysis.Results Compared with non-surgical treatment group,the 3-year survival rate (OR:0.07,95 % CI:0.02,0.22 ; Pheterogeneity =0.93,P < 0.00001),the 5-year survival rate (OR:0.19,95 % CI:0.15,0.24 ; Pheterogeneity = 0.11,< 0.00001) were significantly increased in the surgical group.Conclusions Surgical resection is the preferred treatment of gastroenteropancreatic neuroendocrine tumors in patients with liver metastasis.Surgery is safe and effective,furthermore it takes the advantages of significantly extend the surgical live time.